本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Satsuma Pharmaceuticals, Inc.

1.10
0.0000
成交量:- -
成交额:194.18万
市值:3,646.77万
市盈率:-0.55
高:1.10
开:1.10
低:1.10
收:1.10
数据加载中...
2023/06/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/08

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/06/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/06/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/06/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/06/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/06/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/08

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2023/05/31

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2023/05/25

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2023/05/24

SEC问询函

Form CORRESP - Correspondence
2023/05/19

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2023/05/18

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

私有化交易

SC 13E3 - Going private transaction by certain issuers
2023/05/03

重要事件披露

8-K - Current report
2023/05/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/04/28

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]